These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 29802590)

  • 1. Representing Whom? U.K. Health Consumer and Patients' Organizations in the Policy Process.
    Baggott R; Jones KL
    J Bioeth Inq; 2018 Sep; 15(3):341-349. PubMed ID: 29802590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health consumer and patients' organizations in Europe: towards a comparative analysis.
    Baggott R; Forster R
    Health Expect; 2008 Mar; 11(1):85-94. PubMed ID: 18275405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One For All, All For One? Collective Representation in Healthcare Policy.
    Jongsma K; Rimon-Zarfaty N; Raz A; Schicktanz S
    J Bioeth Inq; 2018 Sep; 15(3):337-340. PubMed ID: 30014364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The voluntary sector and health policy: the role of national level health consumer and patients' organisations in the UK.
    Baggott R; Jones K
    Soc Sci Med; 2014 Dec; 123():202-9. PubMed ID: 25085720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Big Society in an age of austerity: threats and opportunities for Health Consumer and Patients' Organizations in England.
    Baggott R; Jones K
    Health Expect; 2015 Dec; 18(6):2164-73. PubMed ID: 24602084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Representative Claims in Healthcare: Identifying the Variety in Patient Representation.
    van de Bovenkamp HM; Vollaard H
    J Bioeth Inq; 2018 Sep; 15(3):359-368. PubMed ID: 29882180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Federative patient organizations in a decentralized health-care system: A challenge for representation?
    Mankell A; Fredriksson M
    Health (London); 2021 Nov; 25(6):722-738. PubMed ID: 32191125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Legislating Patient Representation: A Comparison Between Austrian and German Regulations on Self-Help Organizations as Patient Representatives.
    Rojatz D; Fischer J; Van de Bovenkamp H
    J Bioeth Inq; 2018 Sep; 15(3):351-358. PubMed ID: 29968017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention better than cure? Health consumer and patients' organisations and public health.
    Baggott R; Jones KL
    Soc Sci Med; 2011 Aug; 73(4):530-534. PubMed ID: 21802183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical Advocacy Across the Autism Spectrum: Beyond Partial Representation.
    McCoy MS; Liu EY; Lutz ASF; Sisti D
    Am J Bioeth; 2020 May; 20(4):13-24. PubMed ID: 32208091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influencing the national policy process: the role of health consumer groups.
    Jones K; Baggott R; Allsop J
    Health Expect; 2004 Mar; 7(1):18-28. PubMed ID: 14982496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [How to build the legitimacy of patient and consumer participation in health issues?].
    Ghadi V; Naiditch M
    Sante Publique; 2006 Jun; 18(2):171-86. PubMed ID: 16886542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Representation and legitimacy in health policy formulation at a national level: perspectives from a study of health technology eligibility procedures in the United Kingdom.
    Milewa T
    Health Policy; 2008 Mar; 85(3):356-62. PubMed ID: 17936401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge of democratic patient representation: Understanding the representation work of patient organizations through methodological triangulation.
    Fischer J; Van de Bovenkamp HM
    Health Policy; 2019 Jan; 123(1):109-114. PubMed ID: 30528657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Representation and Advocacy for Alzheimer Disease in Germany and Israel.
    Schicktanz S; Rimon-Zarfaty N; Raz A; Jongsma K
    J Bioeth Inq; 2018 Sep; 15(3):369-380. PubMed ID: 30066235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation and coordination in Dutch health care policy-making. A network analysis of the system of intermediate organizations in Dutch health care.
    Lamping AJ; Raab J; Kenis P
    Health Promot Int; 2013 Jun; 28(2):211-22. PubMed ID: 22411896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In whose interest? Relationships between health consumer groups and the pharmaceutical industry in the UK.
    Jones K
    Sociol Health Illn; 2008 Sep; 30(6):929-43. PubMed ID: 18761512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health consumer groups in the UK: a new social movement?
    Allsop J; Jones K; Baggott R
    Sociol Health Illn; 2004 Sep; 26(6):737-56. PubMed ID: 15383039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-help organisations as patient representatives in health care and policy decision-making.
    Rojatz D; Forster R
    Health Policy; 2017 Oct; 121(10):1047-1052. PubMed ID: 28890239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sociological perspective on public participation in health care.
    Contandriopoulos D
    Soc Sci Med; 2004 Jan; 58(2):321-30. PubMed ID: 14604618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.